Experience in > 100 Clinical Research Trials involving the following therapeutic areas:

• Benign Prostatic Hyperplasia (BPH)
• Erectile Dysfunction (ED)
• Female Sexual Dysfunction
• Genital Warts
• High Grade Prostatic Intraepithelial neoplasia
• Hypogonadism (low testosterone)
• Interstitial Cystitis
• Nocturia (nighttime urination)
• Overactive Bladder (OAB)
• Peyronies Disease (penile curvature)
• Premature Ejaculation (PE)
• Prostate Cancer and Bladder Cancer
• Chronic and acute Prostatitis
• Urinary Incontinence (unwanted urinary leakage)

Sponsors:

• Bayer Corporation
• UNIMED Pharmaceutical, Inc.
• Pharmacia
• Schering -Plough
• VIVUS, Inc.
• Pfizer
• GlaxoSmithKline
• Eli Lilly
• Sanofi-Sythelabo, Inc.
• NEXMED
• TAP Pharmaceuticals
• B&B Clinical Innovations
• Innovative Health Solutions
• Spectrum Pharmaceuticals
• Plethora
• Zentaris
• Astellas
• GTX
• Ferring
• Salvat
• Allergan
• Duramed
• Palatin
• Auxilium
• Slate
• Serenity
• BioSante
• Nymox
• Graceway

Dr. Kaminetsky is a board certified urologist. He received his degree from NYU School of Medicine and completed his post-graduate training in several of New York's top hospitals. His current appointments include NYU Medical Center, Cabrini Hospital, New York Downtown Medical Center and Saint Vincent's Catholic Medical Center. In addition, Dr. Kaminetsky serves on numerous advisory boards and has membership in six professional societies. He has over 15 years experience in the conduct of Phase II- IV trials.

University Urology Associates has a full-time ACRP Certified Clinical Trials Manger/CCRC, 2 Certified Clinical Research Coordinators and a research assistant. The staff is experienced in working with Sponsors, CROs, and the Central IRB to ensure patient safety, accurate data collection, and timely document submission.

The Study Team has received SAF-T-PAK/IATA Compliance Training and is proficient with electronic data capture, electronic diaries and equipment. The staff is also GCP, HIPPA and NIH trained.

Our location in Manhattan exposes us to a wide variety of patient demographics. New York City is the largest city in the United States with a population of more than 8 million people. This allows for compliance with FDA standards for ethnically and racially diverse subject expectations. We are centrally located and in close proximity to public transportation allowing for easy access for our subjects and sponsors visits.

Nephrology/Urology